These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 8835322)
1. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy. Eto M; Horita K; Morikawa A; Nakata H; Okada M; Saito M; Nomura M; Abiko A; Iwashima Y; Ikoda A Clin Genet; 1995 Dec; 48(6):288-92. PubMed ID: 8835322 [TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus. Horita K; Eto M; Makino I Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM. Kimura H; Suzuki Y; Gejyo F; Karasawa R; Miyazaki R; Suzuki S; Arakawa M Am J Kidney Dis; 1998 Apr; 31(4):666-73. PubMed ID: 9531184 [TBL] [Abstract][Full Text] [Related]
4. [Apolipoprotein E epsilon 2 allele and diabetic nephropathy]. Eto M; Saito M; Kaku K Nihon Rinsho; 2001 Mar; 59 Suppl 3():807-11. PubMed ID: 11347178 [No Abstract] [Full Text] [Related]
5. Higher frequency of apolipoprotein E2 allele in type 2 diabetic patients with nephropathy in Taiwan. Hsieh MC; Lin SR; Yang YC; Chen HC; Lin JN; Shin SJ J Nephrol; 2002; 15(4):368-73. PubMed ID: 12243365 [TBL] [Abstract][Full Text] [Related]
6. [The relationship of Apo E2 and renal insufficiency lipid levels in NIDDM]. Xiang G; Xia B; He Y Zhonghua Yi Xue Za Zhi; 1999 May; 79(5):339-41. PubMed ID: 11715472 [TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E polymorphism and renal function in German type 1 and type 2 diabetic patients. Werle E; Fiehn W; Hasslacher C Diabetes Care; 1998 Jun; 21(6):994-8. PubMed ID: 9614620 [TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E allele frequencies in non-insulin-dependent diabetes mellitus with hypertriglyceridemia (type IIb, III, IV, and V hyperlipoproteinemia). Eto M; Watanabe K; Makino I; Ishii K Metabolism; 1991 Aug; 40(8):776-80. PubMed ID: 1861626 [TBL] [Abstract][Full Text] [Related]
9. [Insulin receptor substrate-1 and glucose transporter gene polymorphisms in noninsulin-dependent diabetes mellitus]. Liu Z; Guan T; Chen Z Zhonghua Yi Xue Za Zhi; 1998 Sep; 78(9):662-5. PubMed ID: 11038788 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genetic polymorphism, remnant lipoproteins, and nephropathy in type 2 diabetic patients. Eto M; Saito M; Okada M; Kume Y; Kawasaki F; Matsuda M; Yoneda M; Matsuki M; Takigami S; Kaku K Am J Kidney Dis; 2002 Aug; 40(2):243-51. PubMed ID: 12148096 [TBL] [Abstract][Full Text] [Related]
11. Phenotypes of apolipoprotein E and abnormalities in lipid metabolism in patients with non-insulin-dependent diabetes mellitus. Imari Y; Koga S; Ibayashi H Metabolism; 1988 Dec; 37(12):1134-8. PubMed ID: 3193900 [TBL] [Abstract][Full Text] [Related]
12. Co-inheritance of specific genotypes of HSPG and ApoE gene increases risk of type 2 diabetic nephropathy. Liu L; Xiang K; Zheng T; Zhang R; Li M; Li J Mol Cell Biochem; 2003 Dec; 254(1-2):353-8. PubMed ID: 14674716 [TBL] [Abstract][Full Text] [Related]
13. Apo E gene polymorphism on development of diabetic nephropathy. Ilhan N; Kahraman N; Seçkin D; Ilhan N; Colak R Cell Biochem Funct; 2007; 25(5):527-32. PubMed ID: 16933203 [TBL] [Abstract][Full Text] [Related]
14. Lack of relationship in long-term type 1 diabetic patients between diabetic nephropathy and polymorphisms in apolipoprotein epsilon, lipoprotein lipase and cholesteryl ester transfer protein. Genétique de la Nephropathie Diabétique Study Group. Données Epidémiologiques sur le Syndrome d'Insulino-Résistance Study Group. Hadjadj S; Gallois Y; Simard G; Bouhanick B; Passa P; Grimaldi A; Drouin P; Tichet J; Marre M Nephrol Dial Transplant; 2000 Dec; 15(12):1971-6. PubMed ID: 11096142 [TBL] [Abstract][Full Text] [Related]
15. Association between apolipoprotein E polymorphism and nephropathy in Iranian diabetic patients. Karimoei M; Pasalar P; Mehrabzadeh M; Daneshpour M; Shojaee M; Forouzanfar K; Razi F Saudi J Kidney Dis Transpl; 2017; 28(5):997-1002. PubMed ID: 28937055 [TBL] [Abstract][Full Text] [Related]
16. Relationship between Apolipoprotein E polymorphism and nephropathy in type-2 diabetic patients. Leiva E; Mujica V; Elematore I; Orrego R; Díaz G; Prieto M; Arredondo M Diabetes Res Clin Pract; 2007 Nov; 78(2):196-201. PubMed ID: 17481771 [TBL] [Abstract][Full Text] [Related]
17. APOE polymorphism and the progression of diabetic nephropathy in Japanese subjects with type 2 diabetes: results of a prospective observational follow-up study. Araki S; Koya D; Makiishi T; Sugimoto T; Isono M; Kikkawa R; Kashiwagi A; Haneda M Diabetes Care; 2003 Aug; 26(8):2416-20. PubMed ID: 12882872 [TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E polymorphism and the progression of diabetic nephropathy in type 2 diabetes. Tien KJ; Tu ST; Chou CW; Yang CY; Hsiao JY; Shin SJ; Chen HC; Hsieh MC Am J Nephrol; 2011; 33(3):231-8. PubMed ID: 21346330 [TBL] [Abstract][Full Text] [Related]
19. The relationship of the apolipoprotein E gene polymorphism Turkish Type 2 diabetic patients with and without nephropathy. Erdogan M; Eroglu Z; Biray C; Karadeniz M; Cetinkalp S; Kosova B; Gunduz C; Topcuoglu N; Ozgen G; Yilmaz C J Endocrinol Invest; 2009 Mar; 32(3):219-22. PubMed ID: 19542737 [TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E polymorphism and renal disease. Oda H; Yorioka N; Ueda C; Kushihata S; Yamakido M Kidney Int Suppl; 1999 Jul; 71():S25-7. PubMed ID: 10412731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]